EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SARS-CoV-2 Spike Protein Amyloid Fibrils Impair Fibrin Formation and Fibrinolysis

Henrik Westman, Per Hammarström, Sofie Nyström iD

Biochemistry · 2025

DOI: 10.1021/acs.biochem.5c00550 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemistry, 2025. Verfasst von Henrik Westman und 2 weiteren Autor:innen. Beteiligte Einrichtung: Linköping University, IFM-Department of Physics, Chemistry, and Biology, Linköping University, 58183 Linköping, Sweden. Hauptthemen laut MEDLINE: Fibrinolysis, Spike Glycoprotein, Coronavirus, Fibrin, Amyloid. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vetenskapsr?det, Olle Engkvists Stiftelse, Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Long COVID, or postacute sequelae of COVID-19 from SARS-CoV-2 infection, is a persistent debilitating disease affecting multiple systems and organs. Long COVID pathophysiology is a complex and not fully established process. One prevailing theory is that the formation of fibrin amyloid microclots (fibrinaloids), due to SARS-CoV-2 infection, can induce persistent inflammation and capillary blockage. An association between the amyloidogenic Spike protein of SARS-CoV-2 and impaired fibrinolysis was made when it was observed that fibrin clots formed in the presence of a mixture of amyloid fibrils from the spike protein mediated resistance to plasmin lysis. Here, we use purified components from the coagulation cascade to investigate the molecular processes of impaired fibrinolysis using seven amyloidogenic SARS-COV-2 Spike peptides. Five of seven Spike amyloid fibrils appeared not to substantially interfere with the fibrinogen-fibrin-fibrinolysis process in vitro, while two spike fibrils were active in different ways. Spike601 amyloid fibrils (sequence 601-620) impaired thrombin-mediated fibrin formation by binding and sequestering fibrinogen but did not affect fibrinolysis. On the contrary, fibrin clots formed in the presence of Spike685 amyloid fibrils (sequence 685-701) exhibited a marked resistance to plasmin-mediated fibrinolysis. We conclude that Spike685 amyloid fibrils can induce dense fibrin clot networks as well as incorporate fibrin into aggregated structures that resist fibrinolysis. Our study proposes a molecular mechanism for how the Spike protein of SARS-CoV-2 could contribute to the formation of fibrinolysis-resistant microclots observed in long COVID.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FibrinolysisSpike Glycoprotein, CoronavirusFibrinAmyloidSARS-CoV-2COVID-19HumansFibrinogen

Substanzen

Spike Glycoprotein, CoronavirusFibrinAmyloidspike protein, SARS-CoV-2Fibrinogen

Autor:innen und Institutionen

  • Linköping University, IFM-Department of Physics, Chemistry, and Biology, Linköping University, 58183 Linköping, Sweden.
  • SciLifeLab, Linköping University, 58183 Linköping, Sweden.

ORCID-Profile: Sofie Nyström

Förderung

  • Vetenskapsr?det
  • Olle Engkvists Stiftelse
  • Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse

Zitieren

APA

Westman, H., Hammarström, P., & Nyström, S. (2025). SARS-CoV-2 Spike Protein Amyloid Fibrils Impair Fibrin Formation and Fibrinolysis. Biochemistry. https://doi.org/10.1021/acs.biochem.5c00550

Vancouver

Westman H, Hammarström P, Nyström S. SARS-CoV-2 Spike Protein Amyloid Fibrils Impair Fibrin Formation and Fibrinolysis. Biochemistry. 2025. doi:10.1021/acs.biochem.5c00550

BibTeX
@article{Westman2025,
  author = {Westman, Henrik and Hammarström, Per and Nyström, Sofie},
  title = {SARS-CoV-2 Spike Protein Amyloid Fibrils Impair Fibrin Formation and Fibrinolysis},
  journal = {Biochemistry},
  year = {2025},
  doi = {10.1021/acs.biochem.5c00550}
}
Kostenlos starten →